Therapeutic drug monitoring of ceftazidime/avibactam: why one leg is not enough to run.
Milo GattiPierluigi VialeFederico PeaPublished in: The Journal of antimicrobial chemotherapy (2023)
The findings may strengthen the contention that for properly assessing the PK/PD target attainment of ceftazidime/avibactam, both ceftazidime and avibactam concentrations should be measured, given the unpredictability of the ceftazidime-to-avibactam ratio occurring among patients.